Fig. 1From: Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a reviewMechanism of action of Brexpiprazole in cancer. Brexpiprazole modulates the activity of serotonin and dopamine; downregulates expression of CD133+ cells, Bmi1, Nanog, and Sox2; and reduces sphere formation ability of CSCsBack to article page